Gateway Advisory, LLC Alaunos Therapeutics, Inc. Transaction History

Gateway Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 14, 2022	SELL	$1.09 - $1.89 $16,678 - $28,918	-15,301 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$1.44 - $2.73 $22,033 - $41,771	15,301 New	15,301 $28,000
Q1 2018 Apr 20, 2018	SELL	$3.46 - $5.14 $60,764 - $90,268	-17,562 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$4.0 - $6.54 $70,248 - $114,855	17,562	17,562 $73,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Gateway Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Gateway Advisory, LLC with notifications on news.